415 related articles for article (PubMed ID: 17803749)
21. Clinical aspects of cytomegalovirus antiviral resistance in solid organ transplant recipients.
Le Page AK; Jager MM; Iwasenko JM; Scott GM; Alain S; Rawlinson WD
Clin Infect Dis; 2013 Apr; 56(7):1018-29. PubMed ID: 23243176
[TBL] [Abstract][Full Text] [Related]
22. Cytomegalovirus genotypes present in cerebrospinal fluid of HIV-infected patients.
Steininger C; Schmied B; Sarcletti M; Geit M; Puchhammer-Stöckl E
AIDS; 2005 Feb; 19(3):273-8. PubMed ID: 15718837
[TBL] [Abstract][Full Text] [Related]
23. Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact.
Baldanti F; Gerna G
J Antimicrob Chemother; 2003 Sep; 52(3):324-30. PubMed ID: 12888590
[TBL] [Abstract][Full Text] [Related]
24. Clinical strategies for the management of cytomegalovirus infection and disease in allogeneic bone marrow transplant.
Prentice HG; Kho P
Bone Marrow Transplant; 1997 Jan; 19(2):135-42. PubMed ID: 9116610
[TBL] [Abstract][Full Text] [Related]
25. Cytomegalovirus infection: an Indian perspective.
Chakravarti A; Kashyap B; Matlani M
Indian J Med Microbiol; 2009; 27(1):3-11. PubMed ID: 19172051
[TBL] [Abstract][Full Text] [Related]
26. Cytomegalovirus infection in patients with solid-organ transplant. Recently reviewed immunologic response and pathogenicity mechanisms.
Caltenco-Serrano R; Sánchez-Huerta JL; Vargas-Jiménez R; Rodríguez-Suárez RS; Gómez-Barreto D
Rev Latinoam Microbiol; 2001; 43(4):177-82. PubMed ID: 17061506
[TBL] [Abstract][Full Text] [Related]
27. Cytomegalovirus. A common virus causing serious disease.
Rawlinson W; Scott G
Aust Fam Physician; 2003 Oct; 32(10):789-93. PubMed ID: 14596071
[TBL] [Abstract][Full Text] [Related]
28. Prevention of CMV infection in transplant patients.
Fishman JA
Transpl Infect Dis; 1999; 1 Suppl 1():35-9. PubMed ID: 11565586
[TBL] [Abstract][Full Text] [Related]
29. Antiviral drugs for cytomegalovirus diseases.
Biron KK
Antiviral Res; 2006 Sep; 71(2-3):154-63. PubMed ID: 16765457
[TBL] [Abstract][Full Text] [Related]
30. An assessment of donor-to-recipient transmission patterns of human cytomegalovirus by analysis of viral genomic variants.
Manuel O; Pang XL; Humar A; Kumar D; Doucette K; Preiksaitis JK
J Infect Dis; 2009 Jun; 199(11):1621-8. PubMed ID: 19385736
[TBL] [Abstract][Full Text] [Related]
31. Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections.
Razonable RR; Paya CV
Herpes; 2003 Dec; 10(3):60-5. PubMed ID: 14759337
[TBL] [Abstract][Full Text] [Related]
32. The cost-effectiveness of prophylaxis with valaciclovir in the management of cytomegalovirus after renal transplantation.
Legendre C; Beard SM; Crochard A; Lebranchu Y; Pouteil-Noble C; Richter A; Durand-Zaleski I
Eur J Health Econ; 2005 Jun; 6(2):172-82. PubMed ID: 15765243
[TBL] [Abstract][Full Text] [Related]
33. Counterpoint: prevention of cytomegalovirus (CMV) infection and CMV disease in recipients of solid organ transplants: the case for prophylaxis.
Snydman DR
Clin Infect Dis; 2005 Mar; 40(5):709-12. PubMed ID: 15714417
[No Abstract] [Full Text] [Related]
34. [Cytomegalovirus infection in renal transplant recipients].
Basić-Jukić N; Racki S; Kes P; Mustapić Z
Acta Med Croatica; 2008; 62 Suppl 1():69-75. PubMed ID: 18578335
[TBL] [Abstract][Full Text] [Related]
35. Prophylaxis and treatment of cytomegalovirus disease in recipients of solid organ transplants: current approach and future challenges.
Puius YA; Snydman DR
Curr Opin Infect Dis; 2007 Aug; 20(4):419-24. PubMed ID: 17609603
[TBL] [Abstract][Full Text] [Related]
36. GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients.
de la Torre-Cisneros J; Fariñas MC; Castón JJ; Aguado JM; Cantisán S; Carratalá J; Cervera C; Cisneros JM; Cordero E; Crespo-Leiro MG; Fortún J; Frauca E; Gavaldá J; Gil-Vernet S; Gurguí M; Len O; Lumbreras C; Marcos MÁ; Martín-Dávila P; Monforte V; Montejo M; Moreno A; Muñoz P; Navarro D; Pahissa A; Pérez JL; Rodriguez-Bernot A; Rumbao J; San Juan R; Santos F; Varo E; Zurbano F;
Enferm Infecc Microbiol Clin; 2011 Dec; 29(10):735-58. PubMed ID: 21925772
[TBL] [Abstract][Full Text] [Related]
37. Late primary cytomegalovirus infection presenting with acute inflammatory demyelinating polyneuropathy in a heart transplant recipient: a case report and review of the literature.
Hodowanec AC; Simon DM
Transpl Infect Dis; 2012 Oct; 14(5):E116-20. PubMed ID: 22938143
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of cutaneous cytomegalovirus infection in non-acquired immune deficiency syndrome, immunocompromised patients.
Choi YL; Kim JA; Jang KT; Kim DS; Kim WS; Lee JH; Yang JM; Lee ES; Lee DY
Br J Dermatol; 2006 Nov; 155(5):977-82. PubMed ID: 17034528
[TBL] [Abstract][Full Text] [Related]
39. Antiviral strategies to combat cytomegalovirus infections in transplant recipients.
Lischka P; Zimmermann H
Curr Opin Pharmacol; 2008 Oct; 8(5):541-8. PubMed ID: 18662804
[TBL] [Abstract][Full Text] [Related]
40. Laboratory diagnosis of cytomegalovirus infection and disease in immunocompromised patients.
Drew WL
Curr Opin Infect Dis; 2007 Aug; 20(4):408-11. PubMed ID: 17609601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
